Can you treat your teen's gut problems?

Yes, in many cases bloating, constipation, loose stools and stomach pain can be treated.

An imbalance of microbes in the gut can be a leading cause of digestive health problems.

How does biomiq help?

Maintains and supports:

- bowel movement frequency
- healthy stool consistency
- healthy gastrointestinal flora
- digestive health

Reduces and/or relieves:

- hard stools/straining
- discomfort/abdominal pain
- loose stools
- bloating (no longer present in 89% of participants).

What is biomiq?

biomiq is a biotherapeutic product designed to rebalance the microbiome.

biomiq contains a combination of live, clinically-validated bacteria which are scientifically shown to reduce/relieve constipation.

Supporting Literature

Scientifically Supported

Servatus biopharmaceuticals biotechnology company logo

Our products are developed in an exclusive partnership with Australia’s leading microbiome therapeutic R&D company, Servatus Ltd.

How do I order?

Click here to order.

Approximately $1.60 a day + p/h.
Delivery to your door usually takes 3-7 days after purchase.

Supporting Scientific Literature

Lombardo et al. (2009) Clinical evaluation of Lactobacillus paracasei subsp. paracasei F19 with gluco-oligosaccharides in the short-term treatment of irritable bowel syndrome. Microbiological Ecology Health and Diseases. 21: 28-32

Lahner et al. (2012) High-fibre diet and Lactobacillus paracasei B21060 in symptomatic uncomplicated diverticular disease. World Journal of Gastroenterology

Chen et al. (2019) Differential Effects of Lactobacillus casei Strain Shirota on Patients With Constipation Regarding Stool Consistency in China. Journal of Neurogastroenterology.

Kato-Katoaka et al. (2016) Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Microbiota and Relieves Abdominal Dysfunction in Healthy Medical Students Exposed to Academic Stress. Applied Environmental Microbiology

Sandler et al. (2000) Abdominal pain, bloating, and diarrhea in the United States: prevalence and impact. Digestive Disease Science. 45: 1166–71.

Ouwehand (2017) A review of dose-responses of probiotics in human studies. Beneficial Microbes. 8 (2): 143-151.